InterMune Amphotec
Executive Summary
InterMune will promote amphotericin B lipid complex product in combination with Actimmune (interferon gamma 1-b) for systemic fungal diseases with 60 sales reps, following its acquisition of worldwide Amphotec rights from Alza for $9 mil. plus milestone and royalty payments